Debt to EBITDA ratio Analysis of INmune Bio Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of INMB
Dec-23-0.366Very Poor Debt to EBITDA | Dec-22-0.542Very Poor Debt to EBITDA | Growth32.42% |
Debt to EBITDA Analysis of INmune Bio Inc
| Debt to EBITDA Ratio of INMB rose handsomely by 32.42 % this year. |
| Debt to EBITDA Ratio with value of -0.0011 was highest in Year Dec-19 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.542 was lowest in Year Dec-22 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.366 is lower than Average Debt to EBITDA of -0.279 in last five years. |
Other Debt to EBITDA Related Info of INMB that may interest you.
INmune Bio Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| INMB | 10.85 | 11.17 | 2.86 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Low Stability Stock | |
FY - Historical Debt to EBITDA of INmune Bio Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.366 | -0.542 | -0.484 | -0.0028 | -0.0011 | 0 | 0 |
| Change | 32.42 % | -11.97 % | -17175.65 % | -159.37 % | 0 % |
FY Chart of Debt to EBITDA of INmune Bio Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)